HYDEMRandomized Controlled Study Evaluating the Efficacy of Hypnosis by Deportee Method Adapted to Nuclear Medicine
Ericksonian Hypnosis
+ Hypnosis
Alzheimer Disease+11
+ Mental Disorders
+ Brain Diseases
Supportive Care Study
Summary
Study start date: May 26, 2023
Actual date on which the first participant was enrolled.This study is exploring a new way to help patients feel less anxious during nuclear medicine scans, which can be long and require them to stay still. These exams often make patients nervous, which can affect the quality of the results. Traditionally, a type of therapy called Ericksonian hypnosis is used to help patients stay calm, but it requires the therapist to be close to the patient, which can expose them to radiation. This study tests if hypnosis can be just as effective when delivered remotely using a headset and microphone, reducing radiation exposure for the therapist and potentially improving the patient experience. Participants in the study will receive hypnosis sessions either through conventional means, with the therapist nearby, or remotely, using technology. The study observes if the remote method can calm patients just as well as the traditional approach. By measuring anxiety levels before and after the hypnosis sessions using a simple scale, the research aims to determine if the remote method is equally effective. This pilot study will help in planning larger studies and ensure that remote hypnosis can be a safe and effective option in the future for both patients and therapists.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.100 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 80 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location